Cme Group debt and dilution—

Borrowings, liquidity, share count and stock-based dilution.

Total debt

USD millions

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Cash & equivalents

USD millions

$2,144.2M

Net debt

USD millions

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Debt / equity

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Debt / assets

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Net debt / EBITDA

× · TTM

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Debt / FCF

× · TTM

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Interest coverage

× · TTM

25.21×

Current ratio

1.02×

Diluted shares

Million shares

361.28M shares

Basic shares

Million shares

360.68M shares

Share count growth

0.29%

Share repurchases

USD millions

—

Quarterly data

Cme Group capital history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal period	Ended	Total debtUSD millions	Cash & equivalentsUSD millions	Net debtUSD millions	Debt / equity×	Debt / assets%	Net debt / EBITDA×	Debt / FCF×	Interest coverage×	Current ratio×	Diluted sharesMillion shares	Basic sharesMillion shares	Share count growth%	Share repurchasesUSD millions
FY 2026 Q2	Jun 30, 2026	—	2,144.2	—	—	—	—	—	25.21×	1.02×	361.28	360.68	0.29%	—
FY 2026 Q1	Mar 31, 2026	—	2,391.2	—	—	—	—	—	25.28×	1.02×	363.21	359.32	-0.08%	—
FY 2025 Q4	Dec 31, 2025	—	4,416.9	—	—	—	—	—	24.39×	1.03×	360.25	359.63	0.02%	—
FY 2025 Q3	Sep 30, 2025	—	2,446.8	—	—	—	—	—	24.4×	1.02×	360.42	359.69	0.08%	—
FY 2025 Q2	Jun 30, 2025	—	1,981.3	—	—	—	—	—	25.26×	1.02×	360.36	359.66	0.09%	—
FY 2025 Q1	Mar 31, 2025	—	1,405.3	—	—	—	—	—	25.08×	1.02×	360.23	359.61	0.1%	—
FY 2024 Q4	Dec 31, 2024	—	2,892.4	—	—	—	—	—	24.43×	1.01×	360.08	359.57	0.1%	—
FY 2024 Q3	Sep 30, 2024	—	2,322.1	—	—	—	—	—	24.06×	1.02×	359.99	359.4	0.11%	—
FY 2024 Q2	Jun 30, 2024	—	1,789.9	—	—	—	—	—	22.87×	1.02×	359.87	359.33	0.11%	—
FY 2024 Q1	Mar 31, 2024	—	1,436.9	—	—	—	—	—	21.84×	1.01×	359.83	359.26	0.09%	—
FY 2023 Q4	Dec 31, 2023	—	2,912	—	—	—	—	—	21.55×	1.02×	359.65	359.2	0.09%	—
FY 2023 Q3	Sep 30, 2023	—	2,300.2	—	—	—	—	—	20.31×	1.03×	359.62	359.02	0.09%	—
FY 2023 Q2	Jun 30, 2023	—	1,880.1	—	—	—	—	—	19.7×	1.02×	359.43	358.94	0.08%	—
FY 2023 Q1	Mar 31, 2023	—	1,565.2	—	—	—	—	—	19.18×	1.02×	359.31	358.93	0.09%	—
FY 2022 Q4	Dec 31, 2022	—	2,720.1	—	—	—	—	—	18.54×	1.01×	359.11	358.89	0.08%	—
FY 2022 Q3	Sep 30, 2022	—	2,130.1	—	—	—	—	—	18.09×	1.02×	359.29	358.72	0.1%	—
FY 2022 Q2	Jun 30, 2022	—	1,879.5	—	—	—	—	—	17.18×	1.02×	359.21	358.64	0.11%	—
FY 2022 Q1	Mar 31, 2022	—	2,045.7	—	—	—	—	—	16.55×	1.02×	359.18	358.61	0.13%	—
FY 2021 Q4	Dec 31, 2021	—	2,834.9	—	—	—	—	—	15.85×	1.01×	359.03	358.58	0.15%	—
FY 2021 Q3	Sep 30, 2021	—	1,459.4	—	—	—	—	—	15.17×	1.01×	358.99	358.36	0.16%	—
FY 2021 Q2	Jun 30, 2021	—	1,081	—	—	—	—	—	14.64×	1.02×	358.89	358.26	0.16%	—
FY 2021 Q1	Mar 31, 2021	—	936.4	—	—	—	—	—	14.4×	1.02×	358.82	358.15	0.17%	—
FY 2020 Q4	Dec 31, 2020	—	1,633.2	—	—	—	—	—	15.87×	1.01×	358.62	358.05	0.17%	—
FY 2020 Q3	Sep 30, 2020	—	1,332.1	—	—	—	—	—	16.19×	1.02×	358.59	357.79	0.16%	—
FY 2020 Q2	Jun 30, 2020	—	1,405.4	—	—	—	—	—	17.04×	1.02×	358.46	357.69	0.18%	—
FY 2020 Q1	Mar 31, 2020	—	851.7	—	—	—	—	—	17.08×	1.01×	358.46	357.52	0.18%	—
FY 2019 Q4	Dec 31, 2019	—	1,551.4	—	—	—	—	—	14.54×	1.03×	358.35	357.45	1.86%	—
FY 2019 Q3	Sep 30, 2019	—	1,210.1	—	—	—	—	—	14.36×	1.04×	358.37	357.21	5.19%	—
FY 2019 Q2	Jun 30, 2019	—	937.7	—	—	—	—	—	13.48×	1.05×	358.16	357.06	5.18%	—
FY 2019 Q1	Mar 31, 2019	—	997.4	—	—	—	—	—	14.22×	1.04×	358.05	356.89	5.18%	—
FY 2018 Q4	Dec 31, 2018	—	1,374.5	—	—	—	—	—	16.54×	1.01×	352.13	350.92	3.47%	—
FY 2018 Q3	Sep 30, 2018	—	1,406.3	—	—	—	—	—	18.17×	1.09×	341.04	339.59	0.24%	—
FY 2018 Q2	Jun 30, 2018	—	1,098.9	—	—	—	—	—	20.7×	1.08×	340.87	339.47	0.27%	—
FY 2018 Q1	Mar 31, 2018	—	784.6	—	—	—	—	—	20.9×	1.04×	340.75	339.31	0.29%	—
FY 2017 Q4	Dec 31, 2017	—	1,903.6	—	—	—	—	—	19.76×	1.03×	340.56	339.15	0.32%	—
FY 2017 Q3	Sep 30, 2017	—	1,631.1	—	—	—	—	—	19.37×	1.05×	340.33	338.77	0.35%	—
FY 2017 Q2	Jun 30, 2017	—	1,362.3	—	—	—	—	—	18.7×	1.04×	340.02	338.56	0.38%	—
FY 2017 Q1	Mar 31, 2017	—	1,287.8	—	—	—	—	—	18.06×	1.03×	339.95	338.34	0.39%	—
FY 2016 Q4	Dec 31, 2016	—	1,868.6	—	—	—	—	—	17.84×	1.03×	339.36	338.08	0.37%	—
FY 2016 Q3	Sep 30, 2016	—	1,420.5	—	—	—	—	—	17.65×	1.06×	339.14	337.59	0.38%	—
FY 2016 Q2	Jun 30, 2016	—	1,161.1	—	—	—	—	—	18×	1.04×	338.71	337.29	0.37%	—
FY 2016 Q1	Mar 31, 2016	—	1,146	—	—	—	—	—	17.78×	1.04×	338.55	337.01	0.4%	—
FY 2015 Q4	Dec 31, 2015	—	1,692.6	—	—	—	—	—	16.94×	1.03×	338.16	336.84	0.49%	—
FY 2015 Q3	Sep 30, 2015	—	1,434.3	—	—	—	—	—	16.98×	1.04×	338.14	336.32	0.57%	—
FY 2015 Q2	Jun 30, 2015	—	1,151	—	—	—	—	—	16.19×	1.04×	337.8	336.04	0.58%	—
FY 2015 Q1	Mar 31, 2015	—	1,694.8	—	—	—	—	—	15.53×	1.04×	337.42	335.68	0.53%	—
FY 2014 Q4	Dec 31, 2014	—	1,366.1	—	—	—	—	—	14.81×	1.02×	336.78	335.2	0.47%	—
FY 2014 Q3	Sep 30, 2014	—	1,087.9	—	—	—	—	—	12.53×	1.05×	336.17	334.42	0.5%	—
FY 2014 Q2	Jun 30, 2014	—	1,037.3	—	—	—	—	—	11.76×	1.07×	335.8	334.1	0.53%	—
FY 2014 Q1	Mar 31, 2014	—	1,053.7	—	—	—	—	—	11.54×	1.06×	335.64	333.91	0.59%	—
FY 2013 Q4	Dec 31, 2013	—	2,469.7	—	—	—	—	—	10.81×	1.05×	335.42	333.64	0.57%	—
FY 2013 Q3	Sep 30, 2013	—	2,065	—	—	—	—	—	10.77×	1.11×	334.67	332.76	0.42%	—
FY 2013 Q2	Jun 30, 2013	—	1,968	—	—	—	—	—	11.06×	1.05×	334.07	332.34	0.38%	—
FY 2013 Q1	Mar 31, 2013	—	1,843.4	—	—	—	—	—	11.59×	1.04×	333.37	331.95	0.34%	—
FY 2012 Q4	Dec 31, 2012	—	1,604.7	—	—	—	—	—	12.8×	1.14×	332.83	331.73	0.34%	0
FY 2012 Q3	Sep 30, 2012	—	2,016.9	—	—	—	—	—	14.55×	1.19×	332.46	331.38	-0.27%	0
FY 2012 Q2	Jun 30, 2012	—	1,293.2	—	—	—	—	—	16.22×	1.24×	332.16	331.08	-0.81%	—
FY 2012 Q1	Mar 31, 2012	—	1,061.7	—	—	—	—	—	16.81×	1.15×	331.85	330.82	-1.04%	—
FY 2011 Q4	Dec 31, 2011	—	1,042.3	—	—	—	—	—	17.29×	1.14×	331.75	330.61	-1.04%	0
FY 2011 Q3	Sep 30, 2011	—	829.3	—	—	—	—	—	17×	1.15×	333.34	332.29	-0.15%	155.1
FY 2011 Q2	Jun 30, 2011	—	693.6	—	—	—	—	—	15.1×	1.23×	334.87	333.8	1.79%	—
FY 2011 Q1	Mar 31, 2011	—	664.7	—	—	—	—	—	13.96×	1.23×	335.31	334.28	0.94%	—
FY 2010 Q4	Dec 31, 2010	—	855.2	—	—	—	—	—	13.05×	1.13×	335.07	334.08	0.56%	0.1
FY 2010 Q3	Sep 30, 2010	—	568.2	—	—	—	—	—	13.06×	1.1×	333.72	332.78	0.26%	279
FY 2010 Q2	Jun 30, 2010	—	363.6	—	—	—	—	—	13.12×	1.06×	328.92	327.91	-1.13%	14.4
FY 2010 Q1	Mar 31, 2010	—	444.2	—	—	—	—	—	12.76×	1.06×	332.14	331.17	—	281.8
FY 2009 Q4	Dec 31, 2009	—	260.6	—	—	—	—	—	11.87×	1.03×	333.24	332.23	—	0
FY 2009 Q3	Sep 30, 2009	—	204.1	—	—	—	—	—	—	1.03×	332.86	331.92	—	0
FY 2009 Q2	Jun 30, 2009	—	448.7	—	—	—	—	—	—	1.06×	332.63	331.65	—	0

Sources and calculations

Financial inputs from company filings. Last checked Oct 18, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Debt uses reported borrowings, with overlapping concepts treated as alternatives. Cash excludes restricted cash and short-term investments. Dilution compares split-normalized weighted average basic shares year over year. Share buyback spending does not by itself measure shares retired.

Market prices: Yahoo Finance · CME, USD. Latest completed close Sep 25, 2026. Price data retrieved Sep 28, 2026.

Total debt: Reported borrowing balances. Uses an aggregate including current maturities, or current plus noncurrent debt. Adds separately disclosed short-term borrowings, with commercial paper as a fallback, unless the selected current/aggregate concept already includes them. Finance leases are included when part of the reported debt concept; undisclosed components are not estimated.
Cash & equivalents: Unrestricted reported cash and cash equivalents. Excludes short-term investments and restricted cash.
Net debt: Total debt − cash and equivalents. Negative means net cash.
Debt / equity: Total debt / equity including noncontrolling interests. Nonpositive equity yields unavailable.
Debt / assets: Total debt / total assets × 100.
Net debt / EBITDA: Period-end net debt / (TTM operating income + TTM depreciation and amortization). Negative net debt is retained.
Debt / FCF: Period-end reported debt / positive TTM free cash flow. Reflects the selected reported capex scope and SBC option.
Interest coverage: TTM operating income / positive TTM interest expense. IFRS finance costs can include more than interest.
Current ratio: Current assets / positive current liabilities.
Diluted shares: Reported weighted average diluted shares, normalized for subsequent recorded stock splits. Fourth-quarter counts use a day-weighted annual/nine-month reconstruction where possible.
Basic shares: Reported weighted average basic shares, normalized for subsequent recorded stock splits.
Share count growth: Year-over-year change in split-normalized weighted average basic shares × 100. A dilution proxy; negative means a lower share count.
Share repurchases: Reported cash payments for repurchase of common shares. This is spending, not a buyback yield.